NRW.Bank

NRW.Bank, headquartered in Düsseldorf, Germany, is a development bank serving the state of North Rhine-Westphalia. It offers a wide range of financial products and services, including low-interest loans, equity financing, and advisory support, primarily for small and medium-sized businesses, as well as initiatives in fields like housing, infrastructure, and innovation. The bank also provides funding for start-ups, social housing, urban development, and environmental projects. It operates competitively neutral, partnering with banks and savings institutions, and combines state, federal, and EU promotion programs with its own products.

Matthias Bolowski

Investment Manager

105 past transactions

Vytal

Venture Round in 2025
Vytal provides software-enabled reusable packaging solutions aimed at reducing single-use packaging waste in the food and beverage industry. The company offers a reusable container system and accompanying container management software designed to support sustainable takeaway and delivery services. Its services cater to a diverse clientele, including restaurants, supermarkets, caterers, canteens, and event organizers. Vytal's platform allows businesses and individual consumers to access high-quality reusable packaging at a pay-per-use price that is more economical than disposable options. Users can conveniently borrow containers for free and return them at various locations or through delivery services, thereby facilitating a circular approach to packaging and contributing to the reduction of plastic waste.

Pilzling

Seed Round in 2025
Pilzling is an urban mushroom farm that specializes in producing gourmet mushrooms by utilizing local waste materials, such as coffee grounds and wood shavings. This innovative approach not only creates nutrient-rich substrates for mushroom cultivation but also contributes to waste reduction and promotes sustainability. The team at Pilzling comprises experts in mycology, biology, and engineering, who work collaboratively to enhance farming methods. By embracing the principles of the circular economy, Pilzling aims to provide consumers with high-quality mushroom products and meat substitutes, while fostering a sustainable regional network.

ScrapBees

Seed Round in 2025
ScrapBees is a pick-up service for recycling scrap metal from public and private residences and businesses. When it comes to converting what was formerly deemed waste into raw material, they are a trustworthy partner for artisans, private homes, and entrepreneurs. the first scrapyard on wheels in the world, quick, technologically advanced, and practical.

alteva

Pre Seed Round in 2025
Alteva is a technology company specializing in the development of advanced battery cells. Its primary focus is on creating high-energy density, safe, and sustainable battery solutions tailored for the decarbonization of hard-to-electrify transportation sectors, including aviation, long-distance trucking, and heavy-duty machinery in industries such as construction, mining, and agriculture. The company's innovative approach involves the use of ultralight carbon materials and sustainable raw materials, ensuring compatibility with existing production facilities.

Refoxy Pharma

Seed Round in 2024
Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity. The company researches FOXO proteins that regulate multiple genes involved in processes like stress resistance, and metabolism and develops novel modulators of a central stress response pathway to modulate aging through genetics, enabling patients to extend the years of healthy living.

GEMESYS

Pre Seed Round in 2024
GEMESYS, a German tech company spun off from Ruhr-University Bochum, specializes in developing advanced AI chips. Utilizing memristors, a novel electronic component, their chips mimic the human brain's information processing, enabling efficient neural network processing. This technology facilitates on-device AI training and inference, opening up new possibilities for Edge AI applications.

Valuedesk

Series A in 2024
Valuedesk GmbH is a service company based in Bielefeld, Germany, that specializes in structured savings and efficiency management. Founded in 2017, Valuedesk provides a comprehensive solution that enables organizations to record, analyze, and implement improvements and savings across various industries, including automotive, biotechnology, energy, food, furniture, construction, chemicals, IT, logistics, telecommunications, electronics, pharmaceuticals, and textiles. The company's adaptable system focuses on cost optimization, utilizing methodologies, workshops, and seminars to enhance transparency and communication within teams. By applying systematic approaches and technology, Valuedesk helps clients identify hidden savings and optimization potentials, develop tailored implementation concepts, and achieve long-term profitability.

Sphingotec

Series C in 2024
Sphingotec GmbH, established in 2002 and based in Brandenburg, Germany, specializes in developing blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions. These conditions include acute heart failure, acute kidney injury, and circulatory shock. The company's portfolio also extends to developing monoclonal antibody therapies in combination with targeted diagnostic tests, aiming to improve the management and recovery of critically ill patients.

Eco2Grow

Seed Round in 2024
ECO2GROW is dedicated to assisting industrial small and medium-sized enterprises (SMEs) in navigating the complexities of the renewable energy landscape. The company provides these businesses with direct access to green electricity sourced from solar and wind farms, enabling them to secure long-term, fixed wholesale energy contracts. By integrating energy procurement with energy management, ECO2GROW equips its clients with the tools necessary to reduce pollution and meet their sustainability objectives. This approach helps SMEs achieve their climate goals while benefiting from reliable and affordable renewable energy solutions.

Black Semiconductor

Series A in 2024
Black Semiconductor is a pioneering manufacturer of semiconductor microchips that specializes in integrating photonic circuits with traditional silicon technology. The company has developed a unique approach that merges electronics and photonics using graphene, enabling unprecedented chip-to-chip communication at high data transfer rates and reduced energy consumption. By harnessing the optical properties of graphene, Black Semiconductor's technology facilitates seamless conversion of electrical signals to light, significantly enhancing bandwidth and reducing latency in data transfer. This innovation allows for longer-distance, high-speed connectivity, replacing traditional copper with optical waveguides to ensure efficient data movement. The company's photonic circuits are designed for compatibility with existing semiconductor manufacturing processes, allowing for easy integration into current chip production lines. In 2025, Black Semiconductor expanded its operations with the construction of a new fabrication facility in Aachen, Germany, which will support scalable pilot production of advanced 300mm wafer technology.

Cylib

Series A in 2024
Cylib is a Greentech startup focused on transforming the recycling of lithium-ion batteries in Europe. The company aims to improve the efficiency and sustainability of battery recycling services, playing a crucial role in the green energy transition. By specializing in the recovery of raw materials during the recycling process, Cylib significantly reduces the carbon footprint associated with the entire battery value chain. This approach not only supports electric vehicle manufacturers in minimizing their reliance on newly mined raw materials but also contributes to the overall sustainability of the electric mobility sector.

Prothea Technologies

Series A in 2024
Prothea Technologies is a private medical technology company specializing in lung cancer diagnostics and treatment. Its innovative solution combines a microendoscope with advanced image processing, enabling hospitals to perform both biopsy and therapy in a single visit, enhancing visualization and improving patient outcomes.

CryoTherapeutics

Series B in 2024
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

widu

Pre Seed Round in 2024
widu enables real estate and accommodation companies to source visuals (photography, video, drone) at scale through its serviced marketplace

Companyon Analytics

Pre Seed Round in 2023
Developer of a planning and controlling software designed to offer easy-to-understand visual presentation. The company's software helps in managing director cockpit, digital BWA, balance sheet, reports, visualizations in graphs, liquidity calculation and forecast, planning and scenario analysis, enabling small and medium-sized companies to set up a system for planning, controlling, and liquidity management in minutes to have clarity about their company's financial situation.

consalio

Seed Round in 2023
Consalio is a company that specializes in advisory spend management solutions, offering a SaaS-based platform designed to enhance transparency in external consulting activities and costs. The platform enables organizations to monitor their advisory expenditures in real-time, providing a comprehensive overview that facilitates the identification of potential savings. By improving the comparability of various advisory projects, Consalio empowers companies to negotiate more effectively and maintain control over project scopes. This approach not only optimizes resource allocation for advisory services but also strengthens the communication between companies and their advisors. An online inquiry form is available on Consalio's website for interested parties.

bNear

Pre Seed Round in 2023
bNear is a virtual office platform designed to enhance communication and collaboration for hybrid and remote teams through integration with Microsoft Teams. The platform offers a social space that facilitates faster collaboration and communication among team members, helping to optimize alignment and improve efficiency. By fostering an environment that encourages creativity, team spirit, and motivation, bNear aims to increase employee engagement and enhance the overall work experience.

Elixion Medical

Seed Round in 2023
Elixion helps to attenuate care shortage in hospitals and care units by automated catheter and drain monitoring with medical IoT devices and AI backed analytics.

talpasolutions

Series B in 2023
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Machine2Human Solutions

Convertible Note in 2023
Machine2Human Solutions specializes in AI-driven customer relationship management (CRM) enhancement. Their core product is an intelligent knowledge processing platform that analyzes customer interactions via speech, automates documentation, and creates knowledge bases. This platform aids in decision-making and problem-solving, enabling businesses to effectively communicate their expertise using advanced machine learning and natural language processing techniques.

Refined Laser Systems

Seed Round in 2023
Refined Laser Systems is a biophotonics company that develops advanced laser systems for applications in stimulated Raman scattering (SRS) microscopy and quantum technology. The company focuses on manufacturing innovative devices designed for stain-free tissue diagnostics, allowing for quick and reliable results within minutes. Utilizing fiber-based tunable picosecond laser technology, Refined Laser Systems offers devices that feature fast switching speeds and robust performance, which enhances automation in laboratory settings. This technology enables researchers to significantly reduce the time needed for accurate diagnostics, thereby improving efficiency in scientific and medical research.

VMRay

Series B in 2022
VMRay GmbH specializes in developing advanced software for malware analysis and detection, utilizing innovative hardware virtualization techniques. Founded in 2013 and based in Bochum, Germany, the company offers a suite of products, including VMRay Analyzer for comprehensive malware analysis, VMRay Detector for automated threat detection, VMRay Investigator for digital forensics, and VMRay Email Threat Defender to combat phishing attacks. The VMRay Platform features an agentless, hypervisor-based sandbox that provides high evasion resistance and complete visibility into malware behavior, allowing organizations to accurately monitor and understand malicious activities without altering the analysis environment. This capability results in precise threat detection with minimal false positives, streamlining incident response and enhancing cybersecurity efficiency. VMRay's software empowers businesses to safeguard their assets and infrastructure while delivering critical intelligence for forensic analysis of intrusion attempts.

Certif-ID International GmbH

Seed Round in 2022
Certif-ID International GmbH operates an online platform that facilitates the issuance of blockchain-based digital certificates and badges. The company aims to create a skills ecosystem that connects educators, industries, and candidates, enabling effective sourcing, management, and development of talent aligned with industry standards. By leveraging the European ESCO framework, Certif-ID harmonizes job profiles and matches skills to job requirements. Its intelligent matching engine uses data to link candidates with suitable job opportunities, while the SkillPass feature allows candidates to showcase their qualifications, including video interviews and project work. The platform supports companies in managing internal talent development and addressing skills shortages, particularly in developing markets. Through its interconnected network of training and industry partners, Certif-ID enhances transparency in credential verification and streamlines cross-border recruitment efforts.

Resolve BioSciences

Series B in 2022
Resolve BioSciences GmbH, founded in 2016 and based in Monheim am Rhein, Germany, specializes in spatial multiomics analysis platforms that enhance the understanding of single-cell spatial biology. The company's technology offers a comprehensive, high-resolution view of subcellular gene expression activities, which is crucial for advancements in various fields such as oncology, neuroscience, and infectious diseases. Resolve BioSciences provides a range of services and expertise in bioinformatics, imaging, genomics, transcriptomics, histology, and pathology, among other areas. This innovative approach supports researchers in their efforts to explore complex biological systems and improve outcomes in health and agriculture.

catchHR

Seed Round in 2022
catchHR is a technology company specializing in recruitment software that employs artificial intelligence to streamline the hiring process for businesses. The platform facilitates applicant search, selection, and management, allowing companies to efficiently identify suitable candidates. Its mobile application connects to 600 online channels, enhancing the reach and visibility of job advertisements. With features such as intuitive application forms, automated candidate sourcing, and personality matching, catchHR enables organizations to analyze applicants' skills and traits effectively. By automating various aspects of recruitment, the company helps businesses optimize their hiring efforts and improve overall efficiency in finding the right employees.

consalio

Seed Round in 2022
Consalio is a company that specializes in advisory spend management solutions, offering a SaaS-based platform designed to enhance transparency in external consulting activities and costs. The platform enables organizations to monitor their advisory expenditures in real-time, providing a comprehensive overview that facilitates the identification of potential savings. By improving the comparability of various advisory projects, Consalio empowers companies to negotiate more effectively and maintain control over project scopes. This approach not only optimizes resource allocation for advisory services but also strengthens the communication between companies and their advisors. An online inquiry form is available on Consalio's website for interested parties.

Drop Friends

Pre Seed Round in 2022
Drop Friends is an app that accepts packages for your community and ties them to an office or hotel at the time of delivery. It is a platform for parcel shipments.

icho

Seed Round in 2022
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

Fimo Health

Seed Round in 2022
Fimo Health is focused on creating an ecosystem for patients experiencing fatigue due to chronic diseases. The company has developed a data-driven health application that combines technology and science to enhance the quality of life for individuals suffering from conditions such as Long Covid, Multiple Sclerosis, and ME/CFS, with plans to expand into Oncology. The application utilizes machine learning to measure relevant data in users' daily lives, empowering them to proactively manage their symptoms. Fimo Health's solution is currently CE-certified for Long Covid and has gained reimbursement from various health insurance providers, reaching over 20 million members.

Einhundert

Venture Round in 2022
Einhundert Energy, founded in 2017 and headquartered in Cologne, Germany, specializes in providing green and digital energy solutions for tenants and property managers. The company offers a comprehensive service package that includes the planning, installation, operation, and maintenance of photovoltaic systems, allowing tenants to access low-cost solar energy. Einhundert Energy also features a digital billing platform that provides transparent monthly billing based on actual power consumption, enabling users to monitor and manage their energy usage through a dedicated app. This system allows for seamless integration with various technologies, including heat and water billing, smoke detectors, heat pumps, and e-charging stations, contributing to consistent cost transparency and efficient energy management.

Emergence Therapeutics

Series A in 2021
Emergence Therapeutics AG is a biopharmaceutical company based in Duisburg, Germany, focused on developing novel antibody-drug conjugate (ADC) immuno-therapeutics for high-need cancers. Founded in 2019, the company is advancing its lead program, which combines a highly specific antibody with optimized linker and payload technology to target Nectin-4, a clinically validated target for various cancers. This approach is inspired by the success of enfortumab vedotin, an approved treatment for urothelial cancers. Emergence Therapeutics is also exploring opportunities to create additional first- or best-in-class ADCs, aiming to address significant therapeutic needs in oncology.

Ducktrain

Seed Round in 2021
Ducktrain specializes in electric semi-autonomous delivery technology aimed at enhancing logistics transportation over longer distances in urban and industrial settings. The company offers innovative vehicle platforms that can be combined into a train-like formation, optimizing the movement of goods while reducing emissions. This technology not only improves efficiency but also promotes environmentally friendly practices in logistics. Ducktrain's solutions allow businesses to upgrade both hardware and software, ensuring that their transport systems remain effective and operational continuously. By focusing on sustainable and efficient transportation methods, Ducktrain is positioned to significantly impact urban and industrial logistics.

Operaize

Seed Round in 2021
Operaize GmbH, based in Cologne, Germany, specializes in developing an artificial intelligence platform known as Cognitive Operations, which is designed to enhance production planning for manufacturing clients. This cloud-based platform integrates seamlessly with existing planning landscapes through APIs or specialized SAP integration, addressing various planning challenges. Cognitive Operations efficiently collects and restructures planning and master data from current ERP and planning systems, allowing it to generate optimal production plans within seconds based on predefined conditions and objectives. Additionally, the platform supports clients in identifying potential faults, risks, and failures in their operations, enabling them to devise effective strategies to mitigate these issues and improve overall efficiency in the industrial value chain.

Coachinho

Seed Round in 2021
Coachinho is a platform dedicated to football coaching and player development, catering to aspiring players, professional coaches, and football enthusiasts. It offers a comprehensive library of coaching drills, tactical strategies, and training sessions created by football experts, covering all levels from beginner to advanced. The platform enhances the coaching experience through interactive skill games and employs advanced AI technology to analyze performance, providing real-time feedback and personalized training recommendations. By focusing on sustainable performance improvement, Coachinho empowers footballers and coaches with the knowledge and tools necessary for optimal game development.

Abalos Therapeutics

Series A in 2021
Abalos Therapeutics GmbH is a biotechnology company based in Essen, Germany, focused on developing innovative immuno-oncology therapeutics. Founded in 2019, the company specializes in arenavirus-based drug candidates aimed at stimulating immune responses to target primary tumors and metastases. Utilizing its proprietary Fast Evolution platform, Abalos Therapeutics generates virus strains with optimized anti-tumoral properties. The company's approach involves reprogramming the immune system to effectively identify and eliminate malignant tumor tissue, thereby offering potential new treatment options for cancer. Through its novel immuno-virotherapy, Abalos Therapeutics seeks to harness the full capabilities of the immune system specifically against cancer cells.

Lumoview Building Analytics

Convertible Note in 2021
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

CEVEC Pharmaceuticals

Venture Round in 2021
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

Masterplan.com

Debt Financing in 2021
Masterplan.com is a developer of a SaaS platform focused on corporate education. The platform provides practical lessons across diverse topics, short learning sessions, and e-learning videos, all designed to facilitate a hands-on review of knowledge. This approach enables users to seamlessly incorporate digital learning into their work routines, enhancing their skills and productivity.

Aifora

Seed Round in 2021
aifora GmbH is a software company based in Düsseldorf, Germany, founded in 2017. It specializes in developing a platform that predicts consumer behavior and offers automation solutions for retail companies. The company's software utilizes big data and machine learning to provide services such as price optimization and inventory management, helping retailers make informed decisions about order quantities and merchandise distribution. By leveraging deep learning algorithms, aifora enables businesses to create customer-centric merchandising strategies, optimize pricing, and manage promotional activities effectively. The platform aims to improve profitability and enhance customer experiences while fostering a shared data ecosystem among brands and retailers. Through intelligent automation, aifora reduces the burden of repetitive tasks, allowing merchandisers to concentrate on product innovation and enhancing consumer engagement.

Semalytix

Series A in 2021
Semalytix GmbH, founded in 2015 and headquartered in Bielefeld, Germany, specializes in developing an artificial intelligence-driven platform designed to extract and summarize trends in the perception of high-cost therapies, particularly in oncology, immunology, and metabolism. The company's flagship tool, Pharos, serves as a real-world evidence generation solution that ingests data from various sources such as CRM systems, social media, job advertisements, and clinical studies. By processing information from patient forums and online discussions, Semalytix organizes this data to provide the pharmaceutical industry with valuable insights. This enables the medical community to make informed decisions that can improve treatment outcomes and enhance the understanding of patient experiences with medications.

eevie - accelerating climate action

Pre Seed Round in 2021
eevie provides a proactive eco-guide aimed at promoting sustainable living. The platform encourages individuals to make mindful choices through actionable insights that highlight the impact of daily decisions on their carbon footprints, covering areas such as commuting, local sourcing, and plastic use reduction. By leveraging machine learning, eevie tailors guidance based on users' daily routines, ensuring relevant and timely support rather than generic solutions. This approach fosters a deeper awareness of environmental issues and facilitates the development of eco-friendly habits over time. Additionally, eevie offers a business-to-business SaaS platform that helps organizations implement customized climate engagement programs, promoting a climate-friendly work culture, measuring emissions, and contributing to environmental, social, and governance (ESG) strategies. Through its technology, eevie aims to unite a global community in the pursuit of sustainable practices, empowering individuals and businesses alike to make meaningful contributions to environmental protection.

Lupiter

Pre Seed Round in 2021
It's better to have a conversation. We help brands to pioneer Conversational Commerce by using WhatsApp. Send out WhatsApp newsletters to your audience. Sell your product or service customers in chat. Engage with your customers directly where their friends are. A conversational commerce suite for consumer brands, who want to talk and build relationships with their customers. We guide brands from setup to sales ready and enable your next marketing and sales channel. 100% personalized.

Coachinho

Seed Round in 2021
Coachinho is a platform dedicated to football coaching and player development, catering to aspiring players, professional coaches, and football enthusiasts. It offers a comprehensive library of coaching drills, tactical strategies, and training sessions created by football experts, covering all levels from beginner to advanced. The platform enhances the coaching experience through interactive skill games and employs advanced AI technology to analyze performance, providing real-time feedback and personalized training recommendations. By focusing on sustainable performance improvement, Coachinho empowers footballers and coaches with the knowledge and tools necessary for optimal game development.

talpasolutions

Series A in 2020
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.

Lupiter

Pre Seed Round in 2020
It's better to have a conversation. We help brands to pioneer Conversational Commerce by using WhatsApp. Send out WhatsApp newsletters to your audience. Sell your product or service customers in chat. Engage with your customers directly where their friends are. A conversational commerce suite for consumer brands, who want to talk and build relationships with their customers. We guide brands from setup to sales ready and enable your next marketing and sales channel. 100% personalized.

Social Impact Network

Convertible Note in 2020
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.

Lumoview Building Analytics

Convertible Note in 2020
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

limbiq.com

Seed Round in 2020
Limbiq provides a browser-based Software-as-a-Service solution focused on supply chain management for B2B clients in various sectors, including industry, trade, and logistics. The company develops artificial intelligence-driven software that digitizes workflow and document management, enhancing operational efficiency. Limbiq's platform integrates all relevant partners, from suppliers to logistics service providers and end customers, facilitating seamless communication and collaboration. This comprehensive tool offers businesses transparency and real-time tracking of goods throughout the entire supply chain, enabling them to optimize their logistics and improve overall performance.

icho

Funding Round in 2020
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

COMPEON

Series C in 2020
COMPEON is a leading financing portal in Germany that specializes in providing small and medium-sized enterprises (SMEs) with tailored financial solutions. By submitting a query on their website, companies can receive customized offers from over 220 banks, leasing companies, and other financial providers at no cost. Annually, COMPEON processes financing inquiries totaling €2.5 billion, offering a diverse range of products including loans, leasing agreements, factoring, mezzanine capital, and project financing. Established in 2013, the company is managed by its founders—Kai Böringschulte, Dr. Nico Peters, and Dr. Frank Wüller—and is backed by investors such as DvH Ventures, b-to-v, and Tengelmann Ventures. Through its online platform, COMPEON enables SMEs to efficiently compare and secure the financial products they need to support their growth and projects.

Ubirch

Seed Round in 2020
Ubirch GmbH, founded in 2014 and based in Cologne, Germany, specializes in developing Internet of Things (IoT) software security solutions utilizing blockchain technology. The company offers a platform that enables the secure transmission and sharing of carbon footprint data, allowing businesses to subscribe and calculate their share of emissions. Ubirch's systems cryptographically sign carbon disclosures, facilitating their reuse within a network and enhancing transparency. This approach addresses the growing importance of climate reduction measures for companies aiming to meet environmental, social, and governance (ESG) criteria. Ubirch serves various industries, including production, insurance, energy, and logistics, helping organizations compile their Scope 3 carbon footprints in an auditable manner.

Lumoview Building Analytics

Funding Round in 2020
Lumoview Building Analytics GmbH, founded in 2019 and based in Cologne, Germany, specializes in developing an indoor measurement system for automated building analysis. The company's technology allows for rapid digitization of buildings, completing the process in just two seconds per room. Using a user-friendly device, Lumoview collects data that is then analyzed in the cloud through a highly automated platform. This connected online system enables building owners to make informed decisions to enhance their properties and reduce CO2 emissions, ultimately contributing to more efficient and sustainable building management.

Chronext

Series E in 2020
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Abalos Therapeutics

Series A in 2019
Abalos Therapeutics GmbH is a biotechnology company based in Essen, Germany, focused on developing innovative immuno-oncology therapeutics. Founded in 2019, the company specializes in arenavirus-based drug candidates aimed at stimulating immune responses to target primary tumors and metastases. Utilizing its proprietary Fast Evolution platform, Abalos Therapeutics generates virus strains with optimized anti-tumoral properties. The company's approach involves reprogramming the immune system to effectively identify and eliminate malignant tumor tissue, thereby offering potential new treatment options for cancer. Through its novel immuno-virotherapy, Abalos Therapeutics seeks to harness the full capabilities of the immune system specifically against cancer cells.

Frontastic

Seed Round in 2019
Frontastic is a developer of a front-end development platform that aims to enhance the digital customer experience. Its Frontend-as-a-Service solution is designed for online retailers, brands, marketplaces, and agile start-ups, emphasizing a "mobile first" approach. This platform enables users to easily implement customer-centric designs with minimal IT resources, allowing for seamless integration of APIs into websites. By providing a user-friendly interface, Frontastic facilitates the creation of customized online presences, positioning itself as a leading front-end solution in the evolving API economy.

Social Impact Network

Convertible Note in 2019
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.

HoloBuilder

Corporate Round in 2019
HoloBuilder Inc. is a software company that specializes in construction progress management through an artificial intelligence-based platform. Founded in 2015 and headquartered in San Francisco, California, HoloBuilder offers a web-based solution that enables construction teams to capture, communicate, and manage project progress using 360-degree photos. The platform integrates with Autodesk BIM 360 and allows users to document construction site progress at every stage. With its subscription-based model, HoloBuilder provides virtual reality capabilities and organizes photos by location and time, allowing engineers, contractors, and clients to virtually visit construction sites at any time. The platform has gained trust from over 28,000 construction projects across 35 countries, helping teams improve efficiency, adhere to schedules, and manage budgets effectively.

Taxy.io

Seed Round in 2019
Taxy.io GmbH, founded in 2018 and based in Aachen, Germany, specializes in automating tax consulting and research through its AI-driven platform, Taxy.io. This platform serves as a central information hub for digital tax intelligence, utilizing machine learning and natural language processing to facilitate semantic and context-specific searches. Taxy.io aims to enhance the efficiency of tax professionals, including lawyers, tax consultants, auditors, and corporate finance employees, by enabling them to quickly access specific information and conduct automated legal analysis. The company's focus is on improving productivity and minimizing compliance risks for accounting firms and tax departments within small to medium-sized enterprises and larger organizations.

Einhundert

Venture Round in 2018
Einhundert Energy, founded in 2017 and headquartered in Cologne, Germany, specializes in providing green and digital energy solutions for tenants and property managers. The company offers a comprehensive service package that includes the planning, installation, operation, and maintenance of photovoltaic systems, allowing tenants to access low-cost solar energy. Einhundert Energy also features a digital billing platform that provides transparent monthly billing based on actual power consumption, enabling users to monitor and manage their energy usage through a dedicated app. This system allows for seamless integration with various technologies, including heat and water billing, smoke detectors, heat pumps, and e-charging stations, contributing to consistent cost transparency and efficient energy management.

Unu motors

Series B in 2018
Unu GmbH, founded in 2013 and headquartered in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company aims to enhance urban mobility by providing stylish, emission-free, and quiet scooters that feature portable batteries, allowing users to charge them conveniently at home. Unu's first electric scooter was launched in 2014, marking the beginning of its commitment to connecting people with their cities. In addition to selling scooters through retail outlets and online, the company offers various financing options and after-sales support services to enhance customer experience.

icho

Seed Round in 2018
icho systems gmbh, based in Duisburg, Germany, specializes in developing interactive therapy solutions for individuals with neurological conditions, particularly dementia, stroke, and Parkinson's disease. The company's flagship product, the ichó therapy ball, employs advanced sensor technology to respond to user interactions—such as rolling, catching, or shaking—with colored lights, sounds, and vibrations. This innovative device is designed to enhance cognitive and motor skills through engaging therapeutic activities, offering over 150 guideline-compliant therapy applications developed in collaboration with healthcare professionals. Since its introduction in 2020, the ichó therapy ball has been implemented in more than 850 facilities, and in 2023, it received funding as a preventive service under care insurance provisions. ichó aims to facilitate outpatient care for patients, ensuring effective therapeutic support in home settings. The product can be purchased directly from the company's website.

Jamata Events

Seed Round in 2018
Jamata Events UG is a company based in Lünen, Germany, founded in 2015, that operates a community platform for event organization and ticket sales. The platform enables event organizers to list their events, while users can search for and purchase tickets from various ticket providers. By aggregating event data from major ticket providers globally, Jamata Events facilitates a comprehensive search for music events, allowing bands, promoters, and event planners to effectively promote their activities.

Holocafé

Seed Round in 2018
Holocafé ist a franchiser company developing exclusive, shared-space VR experiences for location-based entertainment. Content aside, we have developed an entire one-stop platform solution to provide leisure operators with all tools they need: From ticketing and online payment over staff scheduling and accounting to store automization and content distribution. We are presently running three pilot stores in Germany with a fourth one scheduled to open this spring, in addition to a number of international licensees.

Banking One

Pre Seed Round in 2018
Banking One is a developer of a customer relationship platform designed to enhance the understanding of retail bank customers through data-driven insights. The platform enables sales managers to identify customers who are currently interested in financial products, allowing for more targeted engagement. By filtering out the most promising prospects, Banking One helps banks allocate their sales resources more effectively, leading to increased earnings and improved customer satisfaction. Customers are contacted based on their needs rather than being inundated with irrelevant offers, ensuring a more personalized banking experience.

Hemovent

Series A in 2017
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

Unu motors

Series A in 2017
Unu GmbH, founded in 2013 and headquartered in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company aims to enhance urban mobility by providing stylish, emission-free, and quiet scooters that feature portable batteries, allowing users to charge them conveniently at home. Unu's first electric scooter was launched in 2014, marking the beginning of its commitment to connecting people with their cities. In addition to selling scooters through retail outlets and online, the company offers various financing options and after-sales support services to enhance customer experience.

ShopCo Technologies

Seed Round in 2017
ShopCo Technologies Corp. is a technology company based in San Francisco, California, that specializes in enhancing the online shopping experience through its innovative browser extension. The extension features a one-click buy button powered by artificial intelligence, which streamlines the purchasing process by automatically completing transactions on various websites. Founded in 2014 by Jay Habib, ShopCo offers a universal shopping cart that consolidates items from multiple online retailers into a single platform, enabling users to browse and check out seamlessly from one location. Additionally, the company prioritizes user security by employing encryption methods and two-step verification to protect sensitive data. ShopCo Technologies operates as a subsidiary of Klarna Bank AB, further integrating its services within the e-commerce ecosystem.

CardioSecur

Series B in 2017
CardioSecur, a subsidiary of Personal MedSystems, focuses on innovative mobile health solutions, particularly in the realm of instant cardiac monitoring. The company has developed a smartphone-based ECG application that includes a specialized set of electrodes for efficient data collection. This application allows users to conduct personalized cardiac monitoring and facilitates the sharing of results with healthcare providers, enabling patients to receive timely recommendations on their health status in under a minute. By prioritizing ease of use and sophisticated design, CardioSecur aims to deliver professional-grade ECG technology for individuals, enhancing personal health management.

Mapudo

Venture Round in 2016
Mapudo operates as a supplier-independent online marketplace specializing in the trading and processing of metals, primarily steel. The platform serves as a digital distribution channel, connecting metal distributors with buyers in an effort to streamline the procurement process. By offering a standardized product search and a variety of materials, Mapudo enables merchants and buyers to efficiently buy and sell steel products. This innovative approach not only simplifies the transaction process but also helps users save both time and money in their metal procurement activities.

Rigontec

Series A in 2016
Rigontec GmbH is a biopharmaceutical company specializing in RNA-based immunotherapeutics aimed at treating cancer and viral diseases. Founded in 2014 and based in Planegg, Germany, the company focuses on developing compounds that activate the immune receptor retinoic acid-inducible gene I (RIG-I), specifically through its lead product, ImOl100. This compound acts as a minimal mimic of the naturally occurring 3pRNA motif found in viral RNAs, stimulating the immune response effectively. Rigontec's approach circumvents common challenges faced by traditional cancer therapies, such as vaccines and checkpoint inhibitors, by targeting RIG-I pathways to induce tumor cell death and promote long-term immunity. In 2017, Rigontec became a subsidiary of Merck & Co., Inc., enhancing its capabilities in the field of immuno-oncology.

CryoTherapeutics

Series B in 2016
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

Chronext

Series C in 2016
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Hemovent

Series A in 2016
Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

Bomedus

Series B in 2015
Bomedus is a Germany-based medical device company established in 2011, focused on improving mobility for individuals suffering from chronic pain, particularly back pain. The company's innovative devices employ an electro-therapeutic method aimed at providing permanent and sustainable pain reduction. By non-invasively modulating pathologically altered neuronal impulses, Bomedus seeks to enhance the quality of life for patients experiencing chronic discomfort.

Chronext

Series B in 2015
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

CEVEC Pharmaceuticals

Venture Round in 2015
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

PRECIRE Technologies

Venture Round in 2015
PRECIRE Technologies is a leader in speech analysis technology, established in 2012. The company has developed the PRECIRE® platform, which decodes written and spoken language to provide insights into the interactions between personality and behavior. By transforming text into numerous features and comparing them against extensive, psychologically validated reference data sets, the platform delivers precise assessments of communicative effects, emotions, personality traits, and linguistic competence. This technology offers valuable insights into employees, customers, applicants, and other conversational partners, facilitating more intelligent, individualized, and efficient interactions.

Rigontec

Series A in 2015
Rigontec GmbH is a biopharmaceutical company specializing in RNA-based immunotherapeutics aimed at treating cancer and viral diseases. Founded in 2014 and based in Planegg, Germany, the company focuses on developing compounds that activate the immune receptor retinoic acid-inducible gene I (RIG-I), specifically through its lead product, ImOl100. This compound acts as a minimal mimic of the naturally occurring 3pRNA motif found in viral RNAs, stimulating the immune response effectively. Rigontec's approach circumvents common challenges faced by traditional cancer therapies, such as vaccines and checkpoint inhibitors, by targeting RIG-I pathways to induce tumor cell death and promote long-term immunity. In 2017, Rigontec became a subsidiary of Merck & Co., Inc., enhancing its capabilities in the field of immuno-oncology.

Mapudo

Seed Round in 2015
Mapudo operates as a supplier-independent online marketplace specializing in the trading and processing of metals, primarily steel. The platform serves as a digital distribution channel, connecting metal distributors with buyers in an effort to streamline the procurement process. By offering a standardized product search and a variety of materials, Mapudo enables merchants and buyers to efficiently buy and sell steel products. This innovative approach not only simplifies the transaction process but also helps users save both time and money in their metal procurement activities.

Protagen

Venture Round in 2014
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

Vimecon

Venture Round in 2014
Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

Chronext

Series A in 2014
CHRONEXT is a comprehensive platform dedicated to the trading of luxury watches. It facilitates the buying, selling, and servicing of watches through its in-house certified watchmaking atelier. The company provides a wide range of options, including brand new, pre-owned, and vintage timepieces, all of which undergo thorough inspection to ensure quality and authenticity. Through its digital platform, CHRONEXT aims to streamline the luxury watch market for both buyers and sellers.

Rigontec

Series A in 2014
Rigontec GmbH is a biopharmaceutical company specializing in RNA-based immunotherapeutics aimed at treating cancer and viral diseases. Founded in 2014 and based in Planegg, Germany, the company focuses on developing compounds that activate the immune receptor retinoic acid-inducible gene I (RIG-I), specifically through its lead product, ImOl100. This compound acts as a minimal mimic of the naturally occurring 3pRNA motif found in viral RNAs, stimulating the immune response effectively. Rigontec's approach circumvents common challenges faced by traditional cancer therapies, such as vaccines and checkpoint inhibitors, by targeting RIG-I pathways to induce tumor cell death and promote long-term immunity. In 2017, Rigontec became a subsidiary of Merck & Co., Inc., enhancing its capabilities in the field of immuno-oncology.

AYOXXA

Series B in 2014
AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

CryoTherapeutics

Series A in 2014
CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

evocatal

Series B in 2013
evocatal develops and produces enzymes and fine chemicals for the chemical and pharmaceutical industries. We offer a catalog of enzymes (evozymes) as well as and tailor-made biocatalysts for specific industrial applications. Our biocatalysts are applied in various consumer goods industries, including the production and refinement of textiles, adhesives, detergents, nutrition and cosmetics. Our customers regard evocatal as a premium provider of high quality chiral building blocks (evochemicals): from a few grams to several tons. At evocatal we have also continued to focus on providing efficient biocatalytic processes as a service (evoservices). Do you need a biocatalyst for a very specific application? Contact us!

Saperatec

Seed Round in 2013
Saperatec, founded in December 2010, is based in Bielefeld, where it operates comprehensive production facilities focused on the separation of bonded and coated materials. The company specializes in recycling technology that enables the processing of multi-layer materials into secondary raw materials. Utilizing both physical and chemical principles, Saperatec's innovative technology enhances the conversion of waste into recyclable materials, providing valuable recycling alternatives for various products. Additionally, the facility includes a laboratory dedicated to exploring and developing new technologies, further advancing the company's capabilities in the recycling sector.

GreenPocket

Series B in 2012
GreenPocket GmbH, founded in 2009 and based in Cologne, Germany, specializes in energy management software designed for utility companies. The company provides solutions for interpreting and visualizing smart metering data, including a household customer portal and energy management software tailored for commercial clients. Their offerings encompass various tools such as a web portal for real-time energy consumption visualization, a business customer portal for cost-saving comparisons, and smart home solutions that optimize the control of household appliances. By leveraging innovative technologies like artificial intelligence and data science, GreenPocket aims to create significant value from smart meter data, thereby supporting energy suppliers and corporate customers in the transition towards a more sustainable energy future. With experience in over 125 projects across 12 countries, GreenPocket is positioned as a trusted partner in the digitalization of the energy industry.

Azeti

Series A in 2011
Azeti GmbH, based in Berlin, Germany, specializes in Internet of Things (IoT) software solutions that enable industrial companies to optimize their data management and infrastructure. Founded in 2006 and operating as a subsidiary of Aurubis AG since July 2020, Azeti provides a range of M2M solutions, including the SONARPLEX product line, which supports logistics companies in monitoring vehicle conditions, fuel consumption, and driver activities in real-time. The company also offers SonarWise for connecting remote cell sites to network operations, SONARMANAGER as a centralized application for managing appliances, and the azeti Lab app for mobile access. Its Social Sensor Cloud facilitates interaction among sensors and actuators, while the platform supports applications in telecommunications, data centers, and transportation. By delivering tailored solutions and fostering long-term customer relationships, Azeti has successfully implemented numerous projects across diverse industries, focusing on condition monitoring, predictive maintenance, and performance analysis.

CEVEC Pharmaceuticals

Venture Round in 2011
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

NonWoTecc Medical

Series B in 2011
NonWoTecc GmbH was founded with the financial support of High-Tech Gründerfond (HTGF) and Rheinland Venture Capital Fond (RVC) in February of 2007. The goal was to develop a newly designed vascular prosthesis with improved biocompatible and bio-stable properties. NonWoTecc GmbH was one of only seven companies which received a commitment for financial support from HTGF in 2006.

Vimecon

Venture Round in 2011
Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

simfy

Venture Round in 2011
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.

Fashionette

Venture Round in 2011
Fashionette AG is an online retailer specializing in fashion accessories across Europe, offering a wide range of products including handbags, shoes, sunglasses, watches, and jewelry. Founded in 2008 and headquartered in Düsseldorf, Germany, the company focuses on providing customers with a curated selection of luxury items. With a commitment to quality and style, Fashionette has established itself as a prominent player in the online fashion market, catering to a diverse clientele seeking fashionable accessories.

Protagen

Venture Round in 2010
Protagen is a precision medicine company that specializes in drug development and patient management, particularly in the fields of autoimmune diseases and immuno-oncology. The company focuses on immuno-profiling and the discovery of novel autoantibody signatures, utilizing its SeroTag® technology to identify biomarkers that address challenges in the development of cancer immunotherapies and treatments for autoimmune conditions. Protagen is recognized for its expertise in patient stratification, having created disease-specific NavigAID panels that assess individual patients' autoimmune conditions and immune statuses. This tailored approach enables the development of more targeted therapies for various autoimmune diseases, including systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome. Additionally, Protagen's biomarker discovery platform aids in the detection of autoantibodies in patients undergoing cancer immunotherapy, which helps predict treatment responses and supports informed therapeutic decisions.

simfy

Venture Round in 2010
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.

DIREVO Industrial Biotechnology

Series D in 2010
Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.

CEVEC Pharmaceuticals

Series B in 2010
CEVEC Pharmaceuticals GmbH specializes in the manufacture of biopharmaceutical molecules featuring human glycosylation patterns. The company develops the CAP-GO platform, which includes optimized expression vectors and a cell line generation process that is free from serum and animal components. This platform enables the efficient production of complex, glycosylated proteins and therapeutic proteins, including monoclonal antibodies. CEVEC also offers the CAP-GT platform for the industrial-scale production of gene therapy vectors, such as Lentiviral, Adenoviral, and AAV types. Additionally, the company provides contract manufacturing services. Founded in 2001 and based in Cologne, Germany, CEVEC has established a strategic collaboration with BioLamina AB to enhance its capabilities in biopharmaceutical production.

DIREVO Industrial Biotechnology

Venture Round in 2010
Direvo Industrial Biotechnology GmbH, founded in 2008 and based in Cologne, Germany, specializes in developing and marketing biology-based products and processes for non-pharmaceutical industries. The company focuses on providing bio-based solutions in clean energy, clean chemistry, and biomass conversion markets by leveraging its expertise in enzymes and microbes. Its BluZy platform features technologies tailored for the grain ethanol industry, enhancing both the nutritional value of by-products and the efficiency of ethanol production processes. Additionally, the BluServ platform offers automated high-throughput screening for protein and strain engineering, while the BluCon technology facilitates the conversion of non-food feedstocks into carbohydrates for fuel and chemical production. Direvo collaborates with major industry players and is privately owned, with investments from various equity partners and private investors.

audimark GmbH

Venture Round in 2010
Audimark GmbH, based in Aachen, Germany, specializes in providing marketing services specifically tailored for web radios. The company has established itself as a leader in this niche market, focusing on enhancing the visibility and reach of web radio platforms. By offering targeted marketing solutions, Audimark GmbH aims to support web radios in effectively connecting with their audience and maximizing their potential in the digital landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.